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Abstract
Hexabromocyclododecane (HBCD) is a flame retardant that decreases the lytic function of human
natural killer (NK) cells. NK cells defend against tumor cells and virally infected cells. Thus, HBCD
has the potential to increase cancer incidence and viral infections. NK cells must bind to their targets
for lysis to occur. Thus, concentrations of HBCD that decrease lytic function were examined for their
ability to alter NK binding to tumor targets. Levels of HBCD that caused a loss of binding function
were examined for effects on expression of cell surface proteins needed for binding. NK cells exposed
to HBCD for 24 h, 48 h, or 6 days or to HBCD for 1 h followed by 24 h, 48 h, or 6 days in HBCD-
free media were examined for binding function and cell surface protein expression. The results
indicated that exposure of NK cells to 10 μM HBCD for 24 h (which caused a greater than 90% loss
of lytic function) caused a very significant decrease in NK cell binding function (70.9%), and in
CD16 and CD56 cell-surface protein expression (57.8%, and 24.6% respectively). NK cells exposed
to 10 μM HBCD for 1 h followed by 24 h in HBCD-free media (which caused a 89.3% loss of lytic
function) showed decreased binding function (79.2%), and CD 16 expression (48.1%). Results
indicate that HBCD exposures decreased binding function as well as cell-surface marker expression
in NK cells and that these changes may explain the losses of lytic function induced by certain HBCD
exposures.
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INTRODUCTION
Human natural killer (NK) cells are a primary immune defense against tumor cells and virally
infected cells. NK cells prevent the development as well as the metastases of tumors (Lotzova,
1993; Vivier et al., 2004). They also play a central role in defending against viral infections.
Thus, there is increased incidence of viral infections in individuals where the NK subset of
lymphocytes is completely absent (Fleisher et al., 1982; Biron et al., 1989). NK cells are defined
by the absence of the T cell receptor/CD3 complex and by the presence of the CD56 and/or
CD16 on the cell surface (Lotzova, 1993). The NK cell must physically bind to a target cell
(be it a tumor cell or virally infected cell) in order to destroy (lyse) the target. Both CD16 and
CD56 may play a role in NK cell binding to target cells (Lotzova, 1993; Mandelboim et al.,
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1999). As these cells are the front line of immune response against tumor and virally infected
cells (due to their ability to lyse target cells withour prior sensitization), anything that interferes
with their function could lead to an increased incidence of tumors or viral infections.
Hexabromocyclododecane (HBCD) is a widely used brominated flame retardant. In 2001, the
world-wide demand for HBCD was 16,700 metric tons (Covaci et al. 2006). HBCD is used in
polystyrene foams that are used as thermal insulation in the building industry (Kajiwara et al.
2009). Additionally, it is applied to upholstery textiles that are used as furniture, drapery, and
wall coverings (Kajiwara et al. 2009). During the manufacturing process of consumer products
(such as upholstery fabrics), HBCD is usually sprayed on, or impregnated by immersing textiles
in a solution mixed with HBCD (Kajiwara et al., 2009). Since it is not chemically bound to
plastics or textiles, it can separate and leach from the surface of these products into the
environment (de Wit, 2002). HBCD appears to bioaccumulate as it is a very hydrophobic/
lipophilic compound (Germer et al., 2006). Due to its hydrophobic nature it binds to soil,
sediments, and sewage sludge (Hale et al., 2006), and is found in dust particles in the air
(Abdallah et al., 2008). HBCD has been detected in marine animals (Peck et al., 2008) and bird
eggs (Bustnes et al., 2007; Janak et al., 2008; Polder et al., 2008). Its presence in eggs and
animals indicates accumulation/biomagnification in the food chain (Covaci et al., 2006).
Agricultural use of HBCD contaminated sewage sludge (de Boer et al., 2002; Sellstrom et al.,
1999) may be one route to introducing HBCD into the soil and thus into the food chain (Covaci
et al. 2006). One study also found atmospheric deposition of HBCD at a remote site indicating
that the persistence of HBCD is such that it may undergo long-range transport (Remberger et
al., 2004).
Dietary exposures as well as inhalation of contaminated dust particles appear to be major routes
of HBCD exposure for humans (Abdallah et al., 2008). Some seafood contains measurable
levels of HBCD and would thus be a source of dietary exposures (Knutsen et al., 2008; van
Leeuwen et al., 2008). HBCD exposed rainbow trout have decreased cytochrome P4501A
(CYP1A) protein levels and enzyme activity and show an induction of the enzyme, catalase
(Ronisz et al., 2004), while a study of HBCD exposed rats showed increases in CYP2B1 and
CYP2B2 (Germer et al., 2006). Additionally, rats have shown increased liver and pituitary
weight and increased cholesterol in response to HBCD exposures (van der Ven et al., 2006)
and it appears to be neurotoxic in mice (Eriksson et al., 2006). HBCD has been found in human
blood (100 pg/g of whole blood and 200 pg/g serum) (Covaci et al., 2006; Knutsen et al.,
2008), adipose tissue (Pulkrabova et al., 2009), and breast milk (Kakimoto et al., 2008;
Thomsen et al., 2005; Thomsen et al., 2003). Recently, we have shown that human NK cells
exposed to HBCD exhibit significantly decreased ability to destroy tumor target cells (Hinkson
and Whalen, 2009). Importantly, it was shown that the negative effects of an initial HBCD
exposure maintain and/or develop following removal of the compound indicating a potentially
greater risk from any exposure to the compound (Hinkson and Whalen, 2009).
In the current study the effects of HBCD exposures on the ability of NK cells to bind to target
cells was examined. As mentioned earlier, binding is an essential step in the process by which
NK cells lyse target cells. If HBCD exposures were to decrease the ability of NK cells to bind
to targets, this could explain (at least in part) the HBCD-induced loss of lytic function. Certain
cell surface proteins are needed for NK binding to target cells (Lotzova, 1993; Mandelboim et
al., 1999). Effects of both chronic and acute exposures to HBCD were examined for their effects
on binding and cell surface protein expression.
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Isolation of NK cells
Peripheral blood from healthy adult (male and female) volunteer donors was used for this study.
Buffy coats (source leukocytes) obtained from the American Red Cross (Portland, OR) and
Key Biologics, LLC (Memphis, TN) were used to prepare NK cells. Highly purified NK cells
were obtained using a rosetting procedure. Buffy coats were mixed with 0.6–0.8 mL of
RosetteSep human NK cell enrichment antibody cocktail (StemCell Technologies, Vancouver,
British Columbia, Canada) per 45 mL of buffy coat. The mixture was incubated for 25 min at
room temperature (~ 25° C). Following the incubation, 7–8 mL of the mixture was layered
onto 4 mL of Ficoll-Hypaque (1.077 g/mL) (MP Biomedicals, Irvine, CA) and centrifuged at
1200 g for 30–40 min. The cell layer was collected and washed twice with phosphate buffered
saline (PBS) pH 7.2 and stored in complete media (RPMI-1640 supplemented with 10% heat-
inactivated bovine calf serum (BCS), 2 mM L-glutamine and 50 U penicillin G with 50 μg
streptomycin/ml) at 1 million cells/mL. The resulting cell preparation was >95% CD16+, and
CD56+, 0% CD3+ by fluorescence microscopy and flow cytometry (Whalen et al., 2002a).
Chemical preparation
HBCD was purchased from Fisher Scientific. HBCD was dissolved in dimethylsulfoxide
(DMSO) (Sigma-Aldrich, St. Louis, MO) to give a 100 mM stock solution. Desired
concentrations of HBCD were prepared by dilution of the stock into complete media containing
0.5% gelatin in place of the 10% bovine serum. Gelatin replaced BSA to avoid binding of
HBCD to serum albumin, which could interfere with its delivery the cells. The final
concentration of DMSO for HBCD exposures did not exceed 0.01%. Appropriate DMSO
controls were run.
Cell Treatments
NK cells (at a concentration of 1.5 million cells/mL) were exposed to HBCD or Control for
24 h, 48 h or 6 days. Following Exposures, the cells were assayed for binding capacity or cell-
surface marker expression. Additionally, NK cells were exposed to HBCD for 1 h; following
the 1 h exposure period, the HBCD- containing or control media was removed and replaced
with fresh HBCD-free media and the cells were incubated in compound-free media for 24 h,
48 h or 6 days prior being assayed for binding function or cell-surface protein expression. The
concentration range examined was 0.5–10 μM HBCD.
Cell Viability
Cell viability was determined by trypan blue exclusion. Cell numbers and viability were
assessed at the beginning and end of each exposure period. Viability was determined at each
concentration for each of the exposure periods. The viability of treated cells was compared to
that of control cells at each length of exposure (Whalen et al., 2003). Only those concentrations
where viability was unaffected were used at a given length of exposure.
Conjugation Assay
The percentage of target cells with bound NK cells was determined at two effector to target
ratios 12:1 and 6:1. The NK cells were treated as described above. Control and HBCD exposed
NK cells were then suspended at a concentration of 240,000/50 μL (for the 12:1 ratio) and
120,000/50 μL (6:1 ratios). The target cell was the NK-susceptible K562 cell (human chronic
myelogenous leukemia). Target cells were suspended at a concentration of 20,000/50 μL.
Tumor cells (50 μL) were then placed in the wells of microwell plates containing 50 μL of
control or HBCD exposed lymphocytes. Each condition was tested in triplicate. The plate was
centrifuged at 300 g for 3 min and the cells were incubated at 37° C, air/CO2, 19:1, for 10 min
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and then placed on ice. Following the incubation period, the cells were gently resuspended
with a micropipette, placed in a hemacytometer and viewed under a light microscope. The
number of target cells with two or more lymphocytes bound to their surface was counted as
well as the total number of targets to determine the percentage of tumor cells with lymphocytes
bound. The minimum number of targets counted per determination was 50–100 (Whalen et al.,
1992).
Flow Cytometry
NK cells were exposed to the appropriate concentrations of HBCD for the appropriate length
of time. Following exposure to HBCD, the cells were washed and prepared for analysis on a
FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). The cells were washed twice
with ice-cold PBS and 100 μl of cell suspension (250,000–500,000 cells) was labeled with 10
μl of one of the following antibodies: anti-CD2, CD11a, CD11c, CD16, CD18, CD56, TNF-
α, and Fas-L. (Pharmingen, San Diego, CA). Anti- CD2, CD11a, CD16, TNF-α, and Fas-L
were FITC-conjugated antibodies. Anti- CD11c, CD18, and CD56 were phycoerythrin (PE)-
conjugated. Appropriate FITC- and PE-conjugated isotype control antibodies were used. Each
antibody was a monoclonal antibody (mouse IgGκ) that was specific for the human cell surface
protein, such as CD16. Appropriate FITC- and PE-conjugated isotype control antibodies were
used. The antibody-containing cell suspension was incubated for a minimum of 30 minutes on
ice, in the dark. Following the incubation period the cells were washed twice with ice-cold
PBS (1 mL) and suspended in 500 μl of ice-cold 1% paraformaldehyde in PBS. Samples were
analyzed using the the FACSCalibur flow cytometer from Becton Dickinson
Immunocytometry Systems, Inc (BDIS), San Jose, CA. Instrument performance was
standardized weekly using Calibrite beads (BDIS) and the same instrument settings were used
for all acquisitions. The assays were sufficiently uniform to use the same forward scatter (FSC),
side scatter (SSC), and fluorescence (FL) settings. The sensitivity of the instrument was
constant. The acquisition and analysis software for flow cytometry data was CELLQuest Pro
from BDIS running on an Apple computer.
Statistical Analysis
Statistical analysis of the data was carried out utilizing ANOVA and Student’s t test. Data were
initially compared within a given experimental setup by ANOVA. A significant ANOVA was
followed by pair wise analysis of control versus exposed data using Student’s t test, a p value
of less than 0.05 was considered significant.
RESULTS
Effects of Exposures to HBCD for 24 h, 48 h and 6 day on the Binding Function of NK Cells
Highly purified NK cells were exposed to 2.5–10 μM HBCD for 24 h, 2.5μM HBCD for 48
h, and 1–2.5 μM HBCD for 6 days. Exposure to 10 μM HBCD for 24 h lead to a large decrease
in NK cell binding function (70.9% ± 11.8%). At the 2.5 μM and 5 μM concentrations, there
were moderate decreases in binding function (29.5% ± 17.3% and 41.9% ± 19.4% respectively)
(Figure 1). A 48 h exposure to 2.5 μM HBCD caused a significant decrease (37.3% ± 14.6%)
in tumor binding function (Figure 1). When NK cells were exposed to 1 and 2.5 μM of HBCD
for 6 days, there was a significant decrease in tumor binding function (67.6% ± 16.9% and
76.4% ± 16.9% respectively) (Figure 1). To combine results from separate experiments (using
cells from different donors) the tumor binding caused by treated cells was normalized to that
of control cells in a given experiment.
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Effects of Exposures to HBCD for 1 h Followed by 24 h, 48 h, and 6 Days in HBCD-Free Media
on the Binding Function of NK Cells
NK cells were exposed to HBCD for 1 h after which the compound containing media was
removed and the cells were washed two times with compound-free media. The NK cells were
then suspended in HBCD-free media for 24 h, 48 h or 6 days before assaying for tumor binding
function. Exposures of NK cells to 2.5 μM, 5 μM and 10 μM HBCD for 1 h followed by a 24
h incubation in HBCD-free media (Figure 2), caused significant decreases in binding function
(43.0% ± 9.5%, 65.2% ± 18.2% and 79.2% ± 14.9%respectively). When NK cells were exposed
to 2.5 μM, 5 μM, and 10 μM HBCD for 1 h followed by a 48 h period in HBCD-free media,
there were also significant decreases in binding function (48.2% ± 19.9%, 48.1% ± 40.9% and
81.8% ± 15.3%, respectively) (Figure 2). 1 h exposures to 2.5 and 5 μM HBCD followed by
a 6 day incubation in HBCD-free media resulted in large decreases (72.6% ± 13.5% and 88.8%
± 5.0%) in tumor biding function (Figure 2).
Effects of Exposures to HBCD for 24 h, 48 h and 6 Days on Cell-Surface Protein Expression
Levels of key cell surface molecules involved in the NK cell interaction with target cells were
monitored using flow cytometry. Control and HBCD-exposed cells were incubated with
fluorescent-labeled antibodies for specific cell surface markers. The antibodies used were anti-
CD2, CD11a, CD11c, CD16, CD18, CD56, TNF-α, and Fas-L. Of the cell surface proteins
examined, only CD16 and CD56 expression were decreased by exposure of NK cells to HBCD.
When NK cells were exposed to 10 μM HBCD for 24 h, there was a 57.8% ± 24.5% (p< 0.05)
decrease in CD16 expression (as measured by mean fluorescence intensity) and a 24.6%±9.2%
(p<0.05) decrease in CD56 expression. Figures 3A and B shows the shift in peak fluorescence
intensity for a representative experiment. At the 5 μM concentration, there was only a
significant decrease in CD16 expression (63.8±16.5%, p<0.05) (Figure 4, representative
experiment). There was no significant decrease in CD16 or CD56 expression at the 2.5 μM
concentration. When NK cells were exposed to 2.5 μM HBCD for 48 h or 1 or 2.5 μM HBCD
for 6 days, there were no significant decreases in CD16 and CD56 expression.
Effects of Exposure to HBCD for 1 h Followed by 24 h, 48 h, and 6 Days in HBCD-Free Media
on Cell- Surface Protein Expression
Of the cell surface proteins examined, only CD16 expression was decreased. A 1 h exposure
to 10 μM HBCD followed by 24 h in HBCD-free media caused a 48.2% ± 9.8%, (p< 0.05)
decrease in CD16 expression (Figure 5, representative experiment), while a 1 h exposure to 5
μM and 2.5 μM HBCD followed by 24 h in HBCD-free media did not caused a significant
decrease in CD16 expression. Additionally, 1 h exposures to HBCD followed by 48 h or 6 d
incubations in HBCD-free media caused no statistically significant decreases in CD16
expression.
DISCUSSION
In a recent study we found that exposure of human NK cells to the brominated flame retardant,
HBCD, caused very significant decreases in the ability of NK cells to destroy tumor target cells
(Hinkson and Whalen, 2009). This same study showed that a brief exposure to HBCD (1 h)
could induce processes that lead to dramatic decreases in lytic function in the 24 h, 48 h, or 6
day period following the initial exposure. HBCD is an additive flame retardant and is known
to leach from the products to which it is added into the environment (de Wit, 2002). It has been
found in a variety of human tissues (Kakimoto et al., 2008; Pulkrabova et al., 2009; Thomsen
et al., 2005,2003) including human blood (Covaci et al., 2006; Knutsen et al., 2008). The levels
of HBCD found in human blood and serum (0.3 nM in serum) are lower than those where we
see effects on NK lytic function (1 μM), however, there is a possibility of much higher
accumulations in individuals who work in the application of HBCD to the various product in
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which it is used. As we have shown that HBCD has negative effects on human NK immune
function that persist even after its removal, it is important to address further the mechanism of
HBCD-induced loss of NK lytic function. The purpose of the current study was to examine the
effects of HBCD on the ability of NK cells to bind to their targets and to express cell surface
markers, known to be involved in NK binding function, as possible causes of the HBCD-
induced decreases in lytic function. NK cell binding to their targets is the first step of achieving
target lysis. Thus, if HBCD were to interfere with binding, that could at least in part explain
the HBCD-induced loss of lytic function. Since NK cells use specific cell surface proteins to
recognize and bind to their targets, any observed decrease in binding could be explained by an
accompanying decrease in specific cell surface protein expression.
Figure 6 plots the loss of lytic function seen in a previous study (Hinkson and Whalen, 2009)
with the loss of binding function seen in this study for ease of comparison. As shown in Figure
6A, loss of lytic function after 24 h exposures to HBCD was somewhat greater at some
concentrations of HBCD than the loss of binding function. A 48 h exposure to 2.5 μM HBCD
caused NK cells to lose 75.6% of lytic function and 37.3% of binding function (Figure 6B). 6
day exposure HBCD resulted in a large decrease in both lytic and tumor binding function
(Figure 6C). Thus, it appears that the lack of ability of NK cells to bind to their target may be
a significant part of the reason for the loss of lytic function but probably does not explain the
extent of loss of lytic function that has been seen with 24 h and 48 h continuous exposures to
HBCD. Lytic function (Hinkson and Whalen, 2009) and binding function of NK cells exposed
to HBCD for 1 h and then given 24 h, 48 h, or 6 d in HBCD-free media prior to measuring
function are compared in Figure 7. The loss of binding function and loss of lytic function were
similar in extent in these cells indicating that loss of binding function may significantly account
for the loss of lytic function seen under these conditions.
Loss of binding function could be due to loss of specific cell surface proteins utilized by NK
cells to recognize and bind to their targets. Therefore, those HBCD exposures that caused loss
of binding function were examined for their capacity to alter expression of several cell surface
proteins. Certain cell surface markers are known to be involved in NK binding/lytic function.
CD11a, CD18, CD16, and CD56 have all been shown to be important in binding to target cells
(Lotzova, 1993: Mandelboim et al., 1999). The results indicated that there was a very significant
loss of the cell surface proteins CD16 and CD56 in NK cells exposed to 10 μM HBCD for 24
h. Exposure to 5 μM HBCD for 24 h caused a significant decrease in CD16. Following a 1 h
exposure to 10 μM HBCD there was a significant loss of CD16 after 24 h. Although there were
losses of binding function seen after 24 h and 48 exposures to 2.5 μM HBCD and 6 d exposures
to 1μM HBCD, there were no significant decreases in CD16 expression. Thus, decreases in
CD16 expression can but does not necessarily accompany a loss of binding function in the
HBCD exposed NK cells.
Studies examining the relationship between loss of NK binding function accompanying loss
of lytic function have been carried out using other environmental contaminants, including
butyltins, ziram, and another brominated flame retardant, tetrabromobisphenol A (Whalen et
al., 2002a,b; Odman-Ghazi et al., 2003; Taylor et al., 2009; Kibakaya et al., 2009). These
studies, like the current study, have shown that loss of binding function can, but does not
necessarily, accompany a loss of lytic function. The effects of butyltins and ziram on the
expression of cell surface proteins have also shown that there were very significant decreases
in CD16 in NK cells under conditions where binding was decreased (Whalen et al., 2002b;
Odman-Ghazi et al., 2003; Taylor et al., 2009). This is similar to what was seen with HBCD
exposures. Thus loss of CD16 may be at least in part responsible for the loss of binding seen
with HBCD as well as other environmental contaminants that have been shown to interfere
with NK lytic and binding function. Since loss of binding was not always accompanied by
statically significant decreases in CD16 it is likely that other aspects of the NK-target binding
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process are being interfered with upon exposure to HBCD. Previously, it was shown that HBCD
exposures decreased ATP levels in NK cells (Hinkson and Whalen, 2009) and there may be a
role for diminished ATP levels in the decrease in binding as certain process involved in
formation of the synapse between NK cells and target cells are ATP dependent (Andzelm et
al., 2007).
In summary the current study shows: 1.) Exposure of NK cells to HBCD interferes with ability
of NK cells to bind to tumor target cells; 2.) HBCD-induced loss of binding function does not
appear to explain the extent of the loss of NK cell ability to lyse tumor cells under some
conditions; 3.) HBCD-induced loss of binding function can be accompanied by a significant
decrease in the NK cell surface protein CD16, which has a role in NK binding to certain target
cells.
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Effects of 24 h, 48 h and 6 day continuous exposures to HBCD on the ability of NK cells to
bind K562 tumor cells. Light gray bars = NK cells exposed to 1 μM HBCD; Medium gray bars
= NK cells exposed to 2.5 μM HBCD; Dark gray bar = NK cells exposed to 5 μM HBCD;
Black bars = NK cells exposed to 10 μM HBCD. Results are mean±S.D. (n=9 for 24 h and 48
h exposures and n=13 for 6 day exposures). * indicates that the decrease in binding was
statistically significant (p<0.01).
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Effects of a 1h exposures to HBCD followed by 24 h, 48 h and 6 day in HBCD-free media on
the ability of NK cells to bind to K562 tumor cells. Medium gray bars = NK cells exposed to
2.5 μM HBCD; Dark gray bar = NK cells exposed to 5 μM HBCD; Black bars = NK cells
exposed to 10 μM HBCD. Results are mean±S.D. (n=9 for all lengths of exposure). * indicates
that the decrease in binding was statistically significant (p<0.01).
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Histograms from representative experiments showing effects of 24 h exposure to 10 μM HBCD
on CD16 and CD 56 expression in NK cells. A.) 24 h exposure to 10 μM HBCD: Dashed line
= IgG control; thin solid line = control NK cells stained with anti-CD16 antibody; bold line =
HBCD-exposed cells stained with anti-CD16 antibody; y axis = cell number; x axis =
fluorescence intensity. B.) 24 h exposure to 10 μM HBCD: Dashed line = IgG control; thin
solid line = control NK cells stained with anti-CD56 antibody; bold line = HBCD-exposed
cells stained with anti-CD56 antibody; y axis = cell number; x axis = fluorescence intensity.
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Histogram from a representative experiment showing effects of 24 h exposure to 5 μM HBCD
on CD16 expression in NK cells. Dashed line = IgG control; thin solid line = control NK cells
stained with anti-CD16 antibody; bold line = HBCD-exposed cells stained with anti-CD16
antibody; y axis = cell number; x axis = fluorescence intensity. y axis = cell number; x axis =
fluorescence intensity.
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Histogram from representative experiment showing effects of a 1h exposure to 10 μM HBCD
followed by 24 h in HBCD media on CD16 expression in NK cells. Dashed line = IgG control;
thin solid line = control NK cells stained with anti-CD16 antibody; bold line = HBCD-exposed
cells stained with anti-CD16 antibody; y axis = cell number; x axis = fluorescence intensity;
y axis = cell number; x axis = fluorescence intensity.
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Effects of HBCD exposure on lytic function (◆) and binding function (■) (plotted on the same
graph). (A) 24 h exposure to HBCD, (B) 48 h exposure to HBCD, (C) 6 days exposure to
HBCD.
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Effects of 1 h exposures to HBCD followed by varying periods in HBCD-free media on lytic
function (◆) and binding function (■) (plotted on the same graph). (A) 1 h exposure to HBCD
followed by 24 h in HBCD-free media, (B) 1 h exposure to HBCD followed by 48 h in HBCD-
free media, (C) 1 h exposure to HBCD followed by 6 days in HBCD-free media.
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